Back
Euronet Worldwide, Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison
Sell
37
EEFT
Euronet Worldwide, Inc.
Last Price:
$64.08
Seasonality Move:
4.33%
Buy
100
ORKA
Oruka Therapeutics, Inc.
Last Price:
$53.39
Seasonality Move:
5.42%
Sell
37
Euronet Worldwide, Inc. (EEFT)
is a Sell
Is Euronet Worldwide, Inc. a Buy, Sell or Hold?
-
The current Euronet Worldwide, Inc. [EEFT] share price is $64.05. The Score for EEFT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
EEFT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Oruka Therapeutics, Inc. (ORKA)
is a Buy
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
-
ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
EEFT Stock Price Chart
What is Euronet Worldwide, Inc.'s stock price today?
-
The Euronet Worldwide, Inc. share price today is $64.05Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EEFT is experiencing selling pressure, which indicates risk of future bearish movement.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $53.31Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.
EEFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.71 | Sell |
| Relative Strength Index (14 RSI): | 35.38 | Sell |
| Chaikin Money Flow: | -718975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.5 - 72.68) | Sell |
| Bollinger Bands (100): | (69.28 - 75.68) | Sell |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.1 | Buy |
| Relative Strength Index (14 RSI): | 77.59 | Buy |
| Chaikin Money Flow: | 1458349 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.68 - 45.6) | Buy |
| Bollinger Bands (100): | (27.9 - 38.44) | Buy |
EEFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.35 | Sell |
| 20-day SMA: | 68.89 | Sell |
| 50-day SMA: | 70.62 | Sell |
| 200-day SMA: | 82.66 | Sell |
| 8-day EMA: | 66.22 | Sell |
| 20-day EMA: | 68.05 | Sell |
| 50-day EMA: | 70.41 | Sell |
| 200-day EMA: | 80.49 | Sell |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.5 | Buy |
| 20-day SMA: | 41.09 | Buy |
| 50-day SMA: | 36.64 | Buy |
| 200-day SMA: | 25.3 | Buy |
| 8-day EMA: | 47.34 | Buy |
| 20-day EMA: | 42.69 | Buy |
| 50-day EMA: | 37.82 | Buy |
| 200-day EMA: | 28.4 | Buy |
Euronet Worldwide, Inc. Earnings Growth & EEFT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.19 per share, a decrease next quarter of $2.17 per share, an increase this year of $1.12 per share, and an increase next year of $1.32 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.
Euronet Worldwide, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||